Issuer Information

EDGAR: Contact Information
  • Name:
    Cynapsus Therapeutics Inc.
  • Address:
    828 RICHMOND STREET WEST
    TORONTO, ONTARIO, CANADA M6J 1C9
  • Phone:
    416-703-2449
EDGAR: Other Information
  • Jurisdiction:
    CANADA (FEDERAL LEVEL)
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    Cannasat Therapeutics Inc.

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
139598: 0001532079-15-000001
First Sale: 2015-03-31
Security Type(s): Equity
Offer Amount: $16,750,000
Amount Sold: $16,750,000
06b No Notices in EFD for this offering.
93884: 0001532079-14-000002
First Sale: 2014-04-15
Security Type(s): Equity, Each unit is comprised of one common share and one share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$0.81 for a period of 60 months.
Offer Amount: $42,916,967
Amount Sold: $14,546,285
Remaining: $28,370,682
06b No Notices in EFD for this offering.
71256: 0001532079-13-000003
First Sale: 2013-03-01
Security Type(s): Equity, Each unit it comprised of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$0.575 per share for a period of 60 months.
Offer Amount: $13,017,911
Amount Sold: $4,124,454
Remaining: $8,893,457
06 No Notices in EFD for this offering.
71471: 0001532079-13-000002
Security Type(s): Each warrant is exercisable for one common share at an exercise price of Cdn$0.575 per share until February 28, 2015.
Offer Amount: $2,449,104
Remaining: $2,449,104
06 No Notices in EFD for this offering.
44737: 0001532079-12-000002
First Sale: 2011-09-29
Security Type(s): Equity, Debt
Offer Amount: $939,505
Amount Sold: $939,505
06 No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.